Literature DB >> 20674584

Effects of A2 type botulinum toxin on spontaneous miniature and evoked transmitter release from the rat spinal excitatory and inhibitory synapses.

Norio Akaike1, Yushi Ito, Min-Chul Shin, Kiku Nonaka, Yasushi Torii, Tetsuhiro Harakawa, Akihiro Ginnaga, Shunji Kozaki, Ryuji Kaji.   

Abstract

We observed effects of newly developed A2 type botulinum toxin (A2NTX) on spontaneous miniature and evoked transmitter release from inhibitory (glycinergic or GABAergic), or excitatory (glutamatergic) nerve terminals in rat spinal cord, by use of 'synaptic bouton' preparations, under voltage-clamp condition. A2NTX (0.1-1 pM) initially augmented and then decreased amplitude and frequency of spontaneous miniature release of glycine or GABA (mIPSCs) concentration-dependently. At an increased concentration (1-10 pM), A2NTX suppressed the amplitude of glutamatergic mEPSCs. The rank order of the inhibitory effects was glycinergic > GABAergic >> glutamatergic synapses. Focal electrical stimulation of 'synaptic boutons' elicited eIPSC or eEPSC with larger amplitude and low failure rate (Rf). A2NTX (0.01-1 pM) initially enhanced the amplitude or decreased the failure rate of eIPSC or eEPSC, and then almost completely abolished the generation of eIPSC or eEPSC. The action of A2NTX on the evoked transmitter release was partially reversible. The rank order of the inhibitory effects on the amplitude or Rf were glycinergic eIPSC ≥ GABAergic eIPSC > glutamatergic eEPSCs. Excess extracellular K(+) or Ca(2+) (excess [K(+)](o) or [Ca(2+)](o)), and 4-AP restored spontaneous miniature glycinergic, GABAergic or glutamatergic postsynaptic currents suppressed by A2NTX. We conclude that A2NTX inhibits spontaneous miniature release at 0.1-10 pM and evoked release at 0.01-1 pM in rat spinal cord, and the inhibition was much efficient in the evoked rather than the spontaneous miniature release. Excess [K(+)](o), 4-AP and excess [Ca(2+)](o), which can raise the intracellular Ca(2+) concentration via the activation of voltage-dependent Ca(2+) channels, rescue the transmission suppressed by A2NTX poisoning, suggesting the transmitter release machinery became less sensitive to intracellular Ca(2+) in A2NTX poisoned 'synaptic boutons'.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20674584     DOI: 10.1016/j.toxicon.2010.07.015

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  11 in total

Review 1.  Progress in cell based assays for botulinum neurotoxin detection.

Authors:  Sabine Pellett
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

2.  In vivo onset and duration of action varies for botulinum neurotoxin A subtypes 1-5.

Authors:  Sabine Pellett; William H Tepp; Regina C M Whitemarsh; Marite Bradshaw; Eric A Johnson
Journal:  Toxicon       Date:  2015-06-27       Impact factor: 3.033

3.  [Effect of botulinum toxin type B on residual limb sweating and pain. Is there a chance for indirect phantom pain reduction by improved prosthesis use?].

Authors:  K-U Kern; M Kohl; U Seifert; T Schlereth
Journal:  Schmerz       Date:  2012-04       Impact factor: 1.107

4.  Transsynaptic inhibition of spinal transmission by A2 botulinum toxin.

Authors:  Norio Akaike; Min-Chul Shin; Masahito Wakita; Yasushi Torii; Tetsuhiro Harakawa; Akihiro Ginnaga; Keiko Kato; Ryuji Kaji; Shunji Kozaki
Journal:  J Physiol       Date:  2012-10-29       Impact factor: 5.182

5.  Intranasal Delivery of Botulinum Neurotoxin A Protects against Hippocampal Neuron Death in the Lithium-Pilocarpine Rat Model.

Authors:  Zhi Huang; Yajun Lian; Yuan Chen; Shuang Li; Haifeng Zhang; Nanchang Xie; Yake Zheng; Shouyi Wu; Yuhan Wang; Wenchao Cheng; Qiaoman Zhang; Chengze Wang; Yinping Shi; Na Xie
Journal:  Neurochem Res       Date:  2019-03-14       Impact factor: 3.996

6.  Accelerated intoxication of GABAergic synapses by botulinum neurotoxin A disinhibits stem cell-derived neuron networks prior to network silencing.

Authors:  Phillip H Beske; Stephen M Scheeler; Michael Adler; Patrick M McNutt
Journal:  Front Cell Neurosci       Date:  2015-04-23       Impact factor: 5.505

Review 7.  Current status and future directions of botulinum neurotoxins for targeting pain processing.

Authors:  Sabine Pellett; Tony L Yaksh; Roshni Ramachandran
Journal:  Toxins (Basel)       Date:  2015-11-04       Impact factor: 4.546

8.  Botulinum toxin suppression of CNS network activity in vitro.

Authors:  Joseph J Pancrazio; Kamakshi Gopal; Edward W Keefer; Guenter W Gross
Journal:  J Toxicol       Date:  2014-02-12

9.  Embryonic Stem Cell-Derived Neurons Grown on Multi-Electrode Arrays as a Novel In vitro Bioassay for the Detection of Clostridium botulinum Neurotoxins.

Authors:  Stephen P Jenkinson; Denis Grandgirard; Martina Heidemann; Anne Tscherter; Marc-André Avondet; Stephen L Leib
Journal:  Front Pharmacol       Date:  2017-02-23       Impact factor: 5.810

10.  Spinal Central Effects of Peripherally Applied Botulinum Neurotoxin A in Comparison between Its Subtypes A1 and A2.

Authors:  Hidetaka Koizumi; Satoshi Goto; Shinya Okita; Ryoma Morigaki; Norio Akaike; Yasushi Torii; Tetsuhiro Harakawa; Akihiro Ginnaga; Ryuji Kaji
Journal:  Front Neurol       Date:  2014-06-23       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.